appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Vaishali Pharma Ltd
VAISHALI
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Vaishali Pharma Limited is a pharmaceutical company engaged in dealing in pharmaceutical formulations, active pharmaceutical ingredient (APIs), surgical products, veterinary supplements, and herbal and nutraceutical products
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Zydus Lifesciences Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Hmm, looks like data is unavailable here. Please come back after some timeRecent EventsAll events
Notice Of Shareholders Meetings-XBRL
VAISHALI PHARMA LIMITED has informed the Exchange about Notice of Shareholders Meeting for Annual General Meeting to be held on 27-Sep-2024 | Download
VAISHALI PHARMA LIMITED has informed the Exchange about Notice of Shareholders Meeting for Annual General Meeting to be held on 27-Sep-2024 | Download
Press Release
Vaishali Pharma Limited has informed the Exchange regarding a press release dated August 29, 2024, titled "Vaishali Pharma Ltd recommends 1:1 Bonus Issue and 1:5 Stock Split; Expects to continue it's Strong Growth Momentum with Innovation". | Download
Vaishali Pharma Limited has informed the Exchange regarding a press release dated August 29, 2024, titled "Vaishali Pharma Ltd recommends 1:1 Bonus Issue and 1:5 Stock Split; Expects to continue it's Strong Growth Momentum with Innovation". | Download
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant